Rare-Disease Progress Is Becoming a Data-Plumbing Problem
The most interesting biotech development of the last forty-eight hours is not a late-stage efficacy readout or a licensing deal.…
Category: Pathogens
Rare Outbreaks Are Becoming Real-Time Clinical Platforms
One of the more consequential healthcare developments of the past two days has arrived far from the usual biotech spotlight.…